Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584948 · ClinicalTrials.gov registry record · NA
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT00584948 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 94 participants.
The verdict
NCT00584948, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if memantine is effective in treating symptoms of Fragile X-associated Tremor Ataxia Syndrome.
Interventions
- DRUG Placebo
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584948
The ClinicalTrials.gov registry entry for NCT00584948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00584948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584948 about?
NCT00584948 is a clinical study titled "Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome". The purpose of this study is to determine if memantine is effective in treating symptoms of Fragile X-associated Tremor Ataxia Syndrome.
What is the current status of trial NCT00584948?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2007-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00584948?
The interventions under investigation include: Placebo (DRUG), Memantine (DRUG).
Who is sponsoring clinical trial NCT00584948?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.